Hyung Jun Ahn - Concepedia

Author

Hyung Jun Ahn

Korea Institute of Science and Technology ORCID

Also Known As

Ahn, Hyung Jun, Ann, David K., Byung Cheol Shin, H.J. Ahn, Hyung Ahn, Hyung J Ahn, Hyung Jun Ahn, Hyung ‐Jun Ahn, Hyung Jun Ahn

Publications

Citations

H-Index

Concepts

All Affiliations

Korea Institute of Science and Technology Samsung Medical Center Konkuk University Seoul National University Sungkyunkwan University

About

Hyung Jun Ahn is an author at Korea Institute of Science and Technology specializing in medicine, cell biology, and nanomedicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	23	5K
2	Engineering	11	11	503
3	Natural Sciences	10	10	4.5K
4	Health Sciences	3	3	138
5	Allergy	1	1	4K

Hyung Jun Ahn

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the use and interpretation of assays for monitoring autophagy Daniel J. Klionsky, Fábio Camargo Abdalla, Hagai Abeliovich, Autophagy MitophagyParticular Autophagy AssaysImmunologyCytoskeletonMultiple Assays	2012	4K
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer Yeongseon Byeon, Jeong‐Won Lee, Whan Soo Choi, Cancer Research	2018	122
Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription Mihue Jang, Jong Hwan Kim, Hae Yun Nam, Nature Communications	2015	105
Nanobubbles from Gas‐Generating Polymeric Nanoparticles: Ultrasound Imaging of Living Subjects Eunah Kang, Hyun Su Min, Jaeyoung Lee, Angewandte Chemie International Edition NanoparticlesCarbon DioxideMedical UltrasoundEngineeringBiofabrication	2009	104
Chimeric Capsid Protein as a Nanocarrier for siRNA Delivery: Stability and Cellular Uptake of Encapsulated siRNA Kyung-Mi Choi, Seung-Hye Choi, Hyesung Jeon, ACS Nano NanomedicineEncapsulated SirnaDrug TargetingChimeric Capsid ProteinNatural Sciences	2011	97
PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer Chitra Risnayanti, Yeong‐Su Jang, Jinju Lee, Scientific Reports	2018	95
Dark Quenched Matrix Metalloproteinase Fluorogenic Probe for Imaging Osteoarthritis Development <i>in Vivo</i> Seulki Lee, Kyeongsoon Park, Seung Young Lee, Bioconjugate Chemistry Mmp-13 Peptide SubstrateEngineeringImmunologyPathologyBiomedical Engineering	2008	84
Designed Nanocage Displaying Ligand-Specific Peptide Bunches for High Affinity and Biological Activity Jae Og Jeon, So‐Youn Kim, Eun-Su Choi, ACS Nano EngineeringPeptide EngineeringAp1-pbncs BoundBiomedical EngineeringVarious Pbncs	2013	77
Crystal Structure of β-d-Xylosidase from Thermoanaerobacterium saccharolyticum, a Family 39 Glycoside Hydrolase Jin Kuk Yang, H.J. Yoon, Hyung Jun Ahn, Journal of Molecular Biology Crystal StructureBiosynthesisBiochemistryNatural SciencesGlycobiology	2003	77
In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy Hee Dong Han, Yeongseon Byeon, Jong‐Hwa Jang, Scientific Reports	2016	73

Page 1